Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
March 31, 2007
Emergence of tempered preferential attachment from optimization
Raissa M D'Souza, Christian Borgs, Jennifer T Chayes, et al.
Neurology
|
June 1, 1981
Treatment of advanced Parkinson disease with pergolide
A Lieberman, M Goldstein, M Leibowitz, et al.
Neurology
|
August 1, 1981
Lisuride in Parkinson disease: efficacy of lisuride compared to levodopa
A Lieberman, M Goldstein, A Neophytides, et al.
Lancet (London, England)
|
November 24, 1979
Pergolide and lisuride for Parkinson's disease
A N Lieberman, M Leibowitz, A Neophytides, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1991
Ovarian control of pituitary hormone secretion in early human pregnancy
A M Emmi, J Skurnick, L T Goldsmith, et al.
Psychopharmacology
|
January 1, 1981
A double-blind comparison of trebenzomine and thioridazine in the treatment of schizophrenia
A Georgotas, L Gerbino, B Jordan, et al.
Clinical Endocrinology
|
August 31, 2002
Effects of a growth hormone receptor antagonist on bone markers in acromegaly
W P Fairfield, G Sesmilo, L Katznelson, et al.
Clinical Endocrinology
|
February 24, 2001
Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study
L Katznelson, D Kleinberg, M L Vance, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 12, 2009
Guidelines for acromegaly management: an update
S Melmed, A Colao, A Barkan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1996
Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study
C Wang, D R Eyre, R Clark, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Proceedings of the National Academy of Sciences of the United States of America
|
March 31, 2007
Emergence of tempered preferential attachment from optimization
Raissa M D'Souza, Christian Borgs, Jennifer T Chayes, et al.
Neurology
|
June 1, 1981
Treatment of advanced Parkinson disease with pergolide
A Lieberman, M Goldstein, M Leibowitz, et al.
Neurology
|
August 1, 1981
Lisuride in Parkinson disease: efficacy of lisuride compared to levodopa
A Lieberman, M Goldstein, A Neophytides, et al.
Lancet (London, England)
|
November 24, 1979
Pergolide and lisuride for Parkinson's disease
A N Lieberman, M Leibowitz, A Neophytides, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1991
Ovarian control of pituitary hormone secretion in early human pregnancy
A M Emmi, J Skurnick, L T Goldsmith, et al.
Psychopharmacology
|
January 1, 1981
A double-blind comparison of trebenzomine and thioridazine in the treatment of schizophrenia
A Georgotas, L Gerbino, B Jordan, et al.
Clinical Endocrinology
|
August 31, 2002
Effects of a growth hormone receptor antagonist on bone markers in acromegaly
W P Fairfield, G Sesmilo, L Katznelson, et al.
Clinical Endocrinology
|
February 24, 2001
Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study
L Katznelson, D Kleinberg, M L Vance, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 12, 2009
Guidelines for acromegaly management: an update
S Melmed, A Colao, A Barkan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1996
Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study
C Wang, D R Eyre, R Clark, et al.
Page
of 3